Phil Robertson

home / authors / phil-robertson

Phil Robertson is associate director, Regional Sales, Pharma Quality Control, at bioMérieux.

Articles

Loading a DNA tube into a PCR (polymerase chain reaction) thermocycler machine in a bioscience laboratory. Concept of science, laboratory and study of diseases. Coronavirus (COVID-19) treatment | Image Credit: © dhvstockphoto - © dhvstockphoto - stock.adobe.com

CGT Diagnostic Testing Partners Require Pioneering Spirit in Rapidly Evolving Landscape

September 3rd 2025

The growing cell and gene therapy (CGT) market is driving demand for innovative, robust diagnostics to meet scaling, regulatory, and quality needs.

Latest Updated Articles

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Human eye close-up in black and white. Extended pupil | Image Credit: © Annashou - stock.adobe.com

Published: August 22nd 2025 | Updated: September 3rd 2025

VeonGen’s Stargardt Disease Gene Therapy Gets FDA RMAT Status

Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services | Image Credit: © Tada Images - stock.adobe.com

Published: August 25th 2025 | Updated: September 3rd 2025

Novo Receives FDA 483 for Acquired Catalent Site

Quality, Risk, and Regulatory Drivers Behind Fully Connected Continuous Manufacturing™ (FCCM™)

Published: July 30th 2025 | Updated: September 3rd 2025

Quality, Risk, and Regulatory Drivers Behind Fully Connected Continuous Manufacturing™ (FCCM™)

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences

All rights reserved.